Clinical Trial Update: The Effect of Choline Alfoscerate on Improvement of Cognitive Function in Elderly Patients With Diabetes [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating choline alfoscerate for cognitive improvement in elderly patients with type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment in Diabetes
• Type 2 Diabetes Mellitus

Drugs mentioned

• Choline alfoscerate (choline alfoscerate)

Snippet

Sponsor: Seoul National University Bundang Hospital | Conditions: Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED